No Data
No Data
Giant Biogene Schedules Key Financial Meeting
Juzi Biotech (02367.HK) plans to hold a board of directors meeting on August 19th to approve mid-year performance.
Juzi Biotechnology (02367.HK) announced on August 6 that the board of directors is scheduled to hold a meeting on Monday, August 19, 2024, to consider and approve the group's interim performance for the six months ending June 30, 2024, and the proposed interim dividend (if any), as well as to deal with other matters.
GIANT BIOGENE: DATE OF BOARD MEETING
Is Weakness In Giant Biogene Holding Co., Ltd. (HKG:2367) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
CMB International: bullish on the rebound of Mainland China's pharmaceutical industry, with continued bullish policy implementation.
Zhaojin International continues to be bullish on Shenzhen Mindray Bio-Medical Electronics, United Imaging Medical, Innovent Bio (01801), Beigene (06160), Genscript Biotech (02273), Kelun Pharma (06990), and Anpac Bio-Medical Science (02367).
HTSC: Different performance for beauty and medical beauty in Q2. Q3 may be more challenging for new product sales during off-season.
In Q3 24, it is the off-season for the industry, but also an important window period for many brand manufacturers to prepare for the November 11 shopping festival. It is recommended to pay close attention to new product developments.
No Data